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Electroencephalographic Reactivity as
Predictor of Neurological Outcome in
Postanoxic Coma: A Multicenter
Prospective Cohort Study
Marjolein M. Admiraal, MSc ,1 Anne-Fleur van Rootselaar, MD, PhD,2
Jeannette Hofmeijer, MD, PhD,3,4 Cornelia W. E. Hoedemaekers, MD, PhD,5
Christiaan R. van Kaam, MSc,5 Hanneke M. Keijzer, MSc,3,6
Michel J. A. M. van Putten, MD, PhD,4,7 Marcus J. Schultz, MD, PhD,1,8,9 and
Janneke Horn, MD, PhD1,8
Objective: Outcome prediction in patients after cardiac arrest (CA) is challenging. Electroencephalographic reactivity (EEG-
R) might be a reliable predictor. We aimed to determine the prognostic value of EEG-R using a standardized assessment.
Methods: In a prospective cohort study, a strictly defined EEG-R assessment protocol was executed twice per day in
adult patients after CA. EEG-R was classified as present or absent by 3 EEG readers, blinded to patient characteristics.
Uncertain reactivity was classified as present. Primary outcome was best Cerebral Performance Category score (CPC) in
6 months after CA, dichotomized as good (CPC = 1–2) or poor (CPC = 3–5). EEG-R was considered reliable for
predicting poor outcome if specificity was ≥95%. For good outcome prediction, a specificity of ≥80% was used. Added
value of EEG-R was the increase in specificity when combined with EEG background, neurological examination, and
somatosensory evoked potentials (SSEPs).
Results: Of 160 patients enrolled, 149 were available for analyses. Absence of EEG-R for poor outcome prediction had
a specificity of 82% and a sensitivity of 73%. For good outcome prediction, specificity was 73% and sensitivity 82%.
Specificity for poor outcome prediction increased from 98% to 99% when EEG-R was added to a multimodal model.
For good outcome prediction, specificity increased from 70% to 89%.
Interpretation: EEG-R testing in itself is not sufficiently reliable for outcome prediction in patients after CA. For poor
outcome prediction, it has no substantial added value to EEG background, neurological examination, and SSEPs. For
prediction of good outcome, EEG-R seems to have added value.
ANN NEUROL 2019;86:17–27
Cardiac arrest (CA) occurs frequently in Western coun-tries, with an estimated incidence ranging between
85 and 110 per 100,000 person-years.1 Despite medical
advances, overall survival rates remain low.1 About half of the
patients admitted to the intensive care unit (ICU) with post-
anoxic coma survive.2–4 The main determinant of outcome is
neurological dysfunction, predominantly resulting from
hypoxic–ischemic brain injury.5 To limit futile treatment in
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patients without a chance of neurologic recovery, and to avoid
unjust withdrawal of life-sustaining treatment (WLST), sev-
eral diagnostic tests have been advocated.6 Traditional
markers predicting poor outcome are absent brainstem
reflexes, bilateral absence of N20 responses on somatosensory
evoked potentials (SSEPs), and electroencephalography
(EEG) at or after 72 hours post-CA. These tests have high
specificity but limited sensitivity for prediction of poor neuro-
logical outcome, ranging between 20 and 50%.6 In recent
years, early EEG background patterns at 12 and 24 hours
were reported to be reliable prognostic markers for both poor
and good outcome.4,7,8 EEG is widely available, and there is
extensive experience in many hospitals.6,9
Besides background patterns, the EEG response to
external stimulation, that is, EEG reactivity (EEG-R), can
also be assessed.6–8,10 Absence of EEG-R has been reported
with a specificity ranging between 70 and 100% for predic-
tion of poor outcome.7,8,10–14 For good outcome, presence
of EEG-R has been shown to result in a specificity between
55 and 95%.7,8 Unfortunately, protocols for EEG-R are
often poorly described and vary widely, and a clear defini-
tion for interpretation of EEG-R is not available.15 The
studies performed so far have been mainly single-center
studies with limited cohort sizes. Nevertheless, EEG-R in
combination with other factors is included in recommenda-
tions for neurological prognostication in comatose patients
after CA.6 Given these limitations, we aimed to determine
the prognostic value of EEG-R for the prediction of out-
come when using a strict and replicable protocol for EEG-R
testing. We aimed to determine the prognostic value of
EEG-R for poor and for good neurological outcome sepa-
rately, because clinical consequences are different in both sit-
uations. In patients with a high probability of poor
outcome, a test confirming this might lead to WLST. In a
patient with a high probability of good outcome, substanti-
ating this would justify more invasive therapies.
In addition, we investigated the additional prognos-
tic value of EEG-R to other prognostic markers for neuro-
logical outcome. We also determined the reliability of the
interpretation of EEG-R.
We hypothesized that EEG-R is a reliable tool for pre-
diction of poor neurological outcome in patients after CA.
Patients and Methods
Design
This was an investigator-initiated prospective multicenter
cohort study conducted in the ICUs of 2 Dutch university-
based hospitals and 1 teaching hospital. The institutional
review board of the Amsterdam University Medical Centers,
the Netherlands, approved the study protocol and waived the
need for written informed consent, as EEG-R assessment and
basic follow-up are part of routine monitoring in comatose
patients after CA. The trial was registered at trialregister.nl
(identifier: NTR6231).
Patients
Consecutive comatose adult patients after CA in whom con-
tinuous EEG (cEEG) monitoring was started within
24 hours after CA were eligible for participation. Exclusion
criteria included traumatic brain injury, acute stroke, pro-
gressive neurodegenerative disease, prearrest modified
Rankin scale ≥4, or prearrest life expectancy ≤6 months
based on comorbidity.
Standard Care and Monitoring
Patients were treated according to local guidelines for coma-
tose CA patients. This included targeted temperature man-
agement (TTM), aiming at 32 or 36C, for 24 hours at all
centers. cEEG monitoring was continued for 3 days unless a
patient regained consciousness. Recordings were done with at
least 9 electrodes, placed according to the international 10-20
system. Additionally, a ground and reference electrode were
placed in the midline. EEGs were recorded with a Viasys
Nicolet (CareFusion, Middleton, WI), BrainQuick ICU
(Micromed, Mogliano Veneto, Italy), or Nihon Kohden sys-
tem (VCM Medical, Leusden, the Netherlands). Decisions
for withdrawal of life support were based on the Dutch rec-
ommendations for prognostication in postanoxic coma.16
These include neurological examination after clearance of sed-
ative drugs by a neurologist, SSEP testing performed after
TTM, and EEG patterns at 72 hours post-CA.6 Biomarkers
are currently not advised in the Dutch guidelines.
EEG Reactivity
For the duration of cEEG monitoring, EEG-R was assessed
twice per day, morning and afternoon, according to a stan-
dardized protocol of commonly used stimuli,15 regardless of
the EEG background pattern. The protocol consisted of a
fixed set of auditory (clapping hands and calling out the
patient’s name), visual (passive eye opening), tactile (intrana-
sal tickling of the nasal septum with a cotton swap), and nox-
ious stimuli (sternal rub). Each stimulus was performed for
5 seconds and applied 3 times in a row with intervals of
30 seconds. The complete stimulus protocol was executed in
all patients. Stimulation was stopped if a patient showed clini-
cal signs of arousal, such as eye opening or localizing, to any
of the stimuli (independent of EEG-R findings).
All EEG-R assessments were made centrally. Three
experienced EEG readers (A.-F.v.R., J.Hor., and M.M.A.),
blinded to the individual patient characteristics and time
interval from resuscitation, independently rated EEG-R off-
line using a custom-made interface in MATLAB R2012b
(MathWorks, Natick, MA). EEG-R was considered present if
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any of the stimuli induced a change in EEG amplitude or fre-
quency at least twice. Artifacts due to muscle activity or other
noise- and stimulus-induced rhythmic or periodic discharges
were not classified as present EEG-R. Incomplete EEG-R
assessments (>2 of the 15 stimuli missing not caused by
arousal of the patient) and assessments obscured by artifacts
were excluded from analysis.
The 3 raters also scored whether they were certain
or uncertain whether EEG-R was present. In the case of
uncertainty, the EEG-R was considered present in the
analysis, to avoid unjust pessimistic test results leading to
an increased number of false positives. When the raters
disagreed on reactivity, the decision as to whether EEG-R
was present was based on the majority vote. As a second-
ary analysis, EEG-R assessments without unanimous
agreement were re-evaluated in a consensus meeting.
For analysis, 1 EEG-R assessment was selected per
patient. This was the first assessment scored as reactive or,
if no reactive assessment was available, the EEG-R assess-
ment where the patient received the lowest dose of seda-
tion. If all EEG-R assessments of a patient were excluded
because of incorrect execution of the protocol, artifacts, or
technical reasons, the patient was excluded from analysis
and we did not include an extra patient.
EEG Background Pattern
Time windows of 5 minutes of EEG recording were selected
from the cEEG at 12 and 24 hours after CA and immediately
before each stimulus protocol. These were scored by the
3 raters according to validated critical care EEG criteria as
defined by the American Clinical Neurophysiology Society
(ACNS), separated into 3 categories (A, B, and C; Table 1).12
Clinical Variables
The following clinical variables were collected: age, sex, location
of CA, arrest witnessed, time to return of spontaneous circula-
tion (ROSC), initial heart rhythm, presumed etiology of CA,
and the results of SSEP recordings if performed. At the time of
each EEG-R assessment, information on temperature, sedative
medication, and pupillary and corneal reflexes was collected.
Outcome
Primary outcome measure was the best achieved neurolog-
ical outcome within 6 months after CA, defined as good
(Cerebral Performance Category score [CPC] = 1–2; no
or mild cerebral impairment) or poor (CPC = 3–5; mod-
erate cerebral impairment, vegetative state, or death).17
Power Calculation
A power calculation was performed for the primary research
question: prognostic value of absent EEG-R for prediction
of poor outcome. This was based on a prevalence of absent
EEG-R of 45% and an expected specificity for the predic-
tion of poor outcome of 94%, both based on pooled exis-
ting data.7,11,18–20 With an alpha error of 0.05, a power of
80%, and 2-tailed testing, we needed 160 patients to reach
the expected specificity level.
Statistical Analysis
The prognostic values of absence of EEG-R for prediction
of poor outcome and presence of EEG-R for good outcome
were described as specificity, sensitivity, positive predictive
value (PPV), and negative predictive value (NPV). Based
on the differences in clinical implications of predicting poor
or good neurological outcome, thresholds for a reliable
marker for poor outcome prediction and good outcome
prediction were chosen differently. EEG-R by itself was
deemed a sufficiently reliable marker for poor outcome if
the specificity was ≥95% with a 95% confidence interval
(CI) of <5%.6 For good outcome, on the other hand, EEG-
R was deemed sufficiently reliable if the specificity was
≥80% with a 95% CI of <10%. We calculated prognostic
value for both situations. CIs were calculated according to
the Clopper–Pearson exact confidence interval method.21
As a sensitivity analysis, prognostic value of EEG-R
was also assessed in several time windows post-CA:
<12 hours, 12 to 24 hours, 24 to 48 hours, and >48 hours
post-CA. For each window, the best available score per
TABLE 1. Electroencephalographic Background
Categories
Category Background Patterns
A • Suppressed background (<10μV) without
discharges
• Suppressed background (<10μV) with
continuous periodic discharges
• Burst-suppression background (with or
without discharges) with suppression
(<10μV) or attenuation (>10μV, but
<50% of background voltage) periods
constituting >50% of the recording
B • Abundant periodic discharges (>50% of
recording).
• Abundant rhythmic SW
(polyspike/spike/sharp and wave; >50% of
recording)
• Unequivocal electrographic seizure (at
least 1)
• Discontinuous background with
suppression periods (<10μV) constituting
>10% of the recording
• Low-voltage background (most activity is
<20 μV)
C Absence of all features stated above
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patient was used for analysis and prognostic values for both
poor and good outcome were calculated. Influence of non-
neurological deaths on the prognostic value of EEG-R was
assessed by excluding these cases and calculating prognostic
value. Influence of sedative medication on EEG-R was
assessed by comparing the proportion of patients receiving
sedation and the median dose between reactive and unre-
active patients.
The additional value of EEG-R to other available
variables was assessed as the increase in prognostic value of
a baseline multimodal prediction algorithm when EEG-R
is added. For prediction of poor outcome, the baseline
algorithm was EEG background category A (see Table 1)
at 24 hours OR bilaterally absent pupillary reflexes and
corneal reflexes on all tests at <72 hours OR bilaterally
absent cortical N20 response on SSEP testing. For
predicting good outcome, the baseline algorithm was EEG
background category C (see Table 1) at 12 hours OR
brainstem reflexes present at all tests at <72 hours.
The reliability of EEG-R interpretation was assessed
by inter- and intrarater variability. Inter-rater variability
among the 3 raters was assessed using intraclass correlation
coefficient (ICC) and 95% CI based on an average-mea-
sures, absolute-agreement, 2-way random-effects model.
For test–retest reliability, the 3 raters scored 30 randomly
selected EEG-R protocols 3 times, mixed with other
EEG-R assessments and in separate batches to omit recog-
nition. Intrarater variability was assessed by ICC and
corresponding 95% CI based on an average-measures,
absolute-agreement, 2-way mixed-effects model.
Difference between outcome groups was described
using chi-square, Fisher exact test, or Mann–Whitney
U test, whichever was appropriate. Probability values
<0.05 were considered statistically significant. Statistical
analyses were performed using MATLAB 2012b. Missing
data were not imputed.
Results
Patients
Patients were enrolled between April 2015 and February
2018. A total of 182 patients were considered eligible, and
160 patients were enrolled (see Fig 1 for details). At the
Amsterdam University Medical Centers 129 patients were
enrolled, Rijnstate Hospital Arnhem included 17 patients,
and University Medical Center Nijmegen included
14 patients. In these 160 patients, 426 EEG-R assess-
ments were executed, of which 51 were excluded because
of artifacts, 10 because of technical issues, and 20 because
the EEG-R assessment was incomplete. The remaining
345 EEG-R assessments in 149 patients were available for
analysis. Examples of present, unsure, and absent EEG-R
are shown in Figure 2.
Patient characteristics are presented in Table 2. Sev-
enty patients (47%) had a poor outcome (9 CPC = 3,
2 CPC = 4, 59 CPC = 5), and 79 (53%) had a good
FIGURE 1: Flowchart according to STARD (Standards for Reporting Diagnostic Accuracy Studies) guidelines of available patients
for inclusion and analysis. EEG-R = electroencephalographic reactivity.
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FIGURE 2: (A) Example of an electroencephalogram (EEG) with present EEG reactivity (EEG-R). The patient was stimulated with a
sternal rub at the location of the marker. EEG configurations are high pass filter = 0.53Hz, low pass filter = 70Hz,
scaling = 50μV/cm. (B) Example of an EEG with uncertain EEG-R. The patient was stimulated with a sternal rub at the location of
the marker. EEG configurations are high pass filter = 0.53Hz, low pass filter = 70Hz, scaling = 70μV/cm. (C) Example of an EEG
with absent EEG-R. The patient was stimulated with a sternal rub at the marker. EEG configurations are high pass filter = 0.53Hz,
low pass filter = 70Hz, scaling = 30μV/cm. The last channel, resp represents data from a movement sensor on the chest for
tracking respiratory movements; the sternal rub is clearly seen in this channel. ECG = electrocardiogram. [Color figure can be
viewed at www.annalsofneurology.org]
July 2019 21
Admiraal et al: EEG Reactivity in Post-Anoxic Coma
outcome (59 CPC = 1 and 20 CPC = 2). Poor outcome
was associated with longer time to ROSC, nonshockable ini-
tial rhythm, absent brainstem reflexes at <72 hours, and
unfavorable EEG patterns at 12 and 24 hours. SSEP record-
ings were done in 38 patients (26%) at a median time of
56 hours post-CA (interquartile range [IQR] = 43–86
hours). WLST was performed in 46 patients (31%). Clinical
signs of arousal leading to premature interruption of the
protocol were observed in 4 (1%) EEG-R assessments.
Prognostic Value of EEG-R
Absence of EEG-R predicted poor outcome with a specificity
of 82% (95% CI = 74–91) and a sensitivity of 73% (95%
CI = 62–83; Tables 3 and 4, A). Nineteen patients had present
EEG-R, but had a poor outcome; 3 had CPC = 3 at 6 months
and 16 died, 6 from a non-neurological cause, 9 from a neuro-
logical cause, and 1 of unknown cause. Of those 9 patients that
died from a neurological cause, SSEPs were tested in 7; in
1 patient, the N20 was bilaterally absent. In the other patients,
a wait and see policy was applied and treatment was withdrawn
when no neurological recovery appeared (median time from
CA to death = 5 days, IQR = 3.5–11 days).
For presence of EEG-R predicting good outcome,
we found 73% (95% CI = 62–83) specificity and 82%
(95% CI = 74–91) sensitivity (see Table 3).
In none of the time windows after CA that we assessed
did specificity for prediction of poor outcome reach our
predefined limit for sufficient reliability (Table 5). After
TABLE 2. Patient Characteristics
Characteristic Good Outcome, n = 79 Poor Outcome, n = 70 p
Demographic characteristics
Age, yr 62 (51–69) 65 (53–74) 0.17
Sex, male 66/79 (84%) 51/70 (73%) 0.16
Characteristics of the cardiac arrest
OHCA 73/79 (92%) 59/70 (84%) 0.13
Witnessed arrest 58/75 (77%) 52/70 (74%) 0.08
Time to ROSC, min 12.5 (9–17.5)a 22 (15–32)b <0.001
Initial rhythm shockable 69/74 (93%) 36/67 (54%) <0.001
Cardiac etiology 47/70 (67%) 45/61 (74%) 0.45
Clinical characteristics during ICU treatment
Absent stem reflexes, <72 h 0/79 (0%) 19/70 (27%) <0.001
Present stem reflexes, <72 h 54/79 (68%) 18/70 (26%) <0.001
Bilaterally absent SSEP N20 0/3 (0%) 11/35 (31%) 0.54
EEG pattern at 12 h <0.001
Category A 0/38 (0%) 20/28 (71%)
Category B 14/38 (37%) 3/28 (11%)
Category C 24/38 (63%) 5/28 (18%)
EEG pattern at 24 h <0.001
Category A 2/75 (3%) 30/66 (45%)
Category B 10/75 (13%) 14/66 (21%)
Category C 63/75 (84%) 22/66 (33%)
Data are presented as median (interquartile range) or n/n (%). For EEG pattern classification, see Table 1.
an = 76.
bn = 63.
EEG = electroencephalographic; ICU = intensive care unit; OHCA = out of hospital cardiac arrest; ROSC = return of spontaneous circulation;
SSEP = median nerve somatosensory evoked potential.
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excluding non-neurological deaths (n = 13), the specificity for
prediction of poor outcome was 82% (95% CI = 72–90) and
the sensitivity was 77% (95% CI = 64-87; see Table 4, B).
Unreactive patients less often received sedative medication
(Table 6). If sedated, dose of propofol or midazolam did not
differ between reactive and unreactive patients.
Additional Prognostic Value of EEG-R
Prediction of poor neurological outcome based on EEG back-
ground at 24 hours post-CA, brainstem reflexes, or SSEPs
resulted in a specificity of 98% (95% CI = 91–100) and the
sensitivity of 54% (95% CI = 42–66). If also EEG-R was
absent, the specificity was 99% (95% CI = 93–100) and the
sensitivity was 51% (95% CI = 39–64; see Table 3 for PPV
and NPV).
For prediction of good neurological outcome based on
EEG background at 12 hours post-CA or brainstem reflexes,
the specificity was 70% (95% CI = 58–80) at 79% (95%
CI = 68–87) sensitivity. When present EEG-R was added, the
specificity increased to 89% (95% CI = 79–95), and the
sensitivity decreased to 66% (95% CI = 54–76; see Table 3 for
PPV andNPV).
Reliability of EEG-R Interpretation
Inter-rater reliability was good, with an ICC of 0.85 (95%
CI = 0.82–0.88). Intrarater variability was moderate on aver-
age: rater A, ICC = 0.68 (95% CI = 0.34–0.85); rater B,
ICC = 0.70 (95% CI = 0.37–0.86); rater C, ICC = 0.83
(95% CI = 0.64–0.92). In the 83 (24%) EEG-R assessments
that were re-evaluated in a consensus meeting, we found poor
agreement between the results of the majority vote and con-
sensus meeting (ICC = 0.40, 95% CI = 0.09–0.61). Based
on consensus meeting results, specificity and sensitivity did
not change (see Table 4, C).
Discussion
In this study, we found that EEG-R in itself is not reliable
enough for prediction of poor or good neurological out-
come in patients after CA. In light of the multimodal
approach to prognostication, the question is to what extent
TABLE 3. Predictive Value of (Combinations of) Clinical and Neurophysiologic Measures
Measure
Available
for
Analysis, n
Predicted
Outcome
Specificity
(95% CI)
Sensitivity
(95% CI) PPV (95% CI)
NPV
(95% CI)
EEG reactivity absent 149 Poor 82% (72–90) 73% (61–83) 79% (67–88) 77% (67–86)
EEG cat. A pattern at 24 h 141 Poor 97% (91–100) 46% (33–58) 94% (79–99) 67% (57–76)
Brainstem reflexes absent 149 Poor 100% (95–100) 27% (17–39) 100% (82–100) 61% (52–69)
SSEP N20 absent 38 Poor 100% (29–100) 31% (17–49) 100% (72–100) 11% (2–29)
Baseline: EEG cat. A
pattern at 24 h OR
brainstem reflexes absent
OR SSEP N20 absent
149 Poor 98% (91–100) 54% (42–66) 95% (83–99) 71% (61–79)
Baseline AND EEG
reactivity absent
149 Poor 99% (93–100) 51% (39–64) 97% (86–100) 70% (60–78)
EEG reactivity present 149 Good 73% (61–83) 82% (72–90) 77% (67–86) 79% (67–88)
EEG cat. C pattern at 12 h 66 Good 82% (63–94) 63% (46–78) 83% (64–94) 62% (45–78)
Brainstem reflexes present 149 Good 74% (62–84) 68% (57–78) 75% (63–85) 68% (56–78)
Baseline: EEG cat. C
pattern at 12 h OR
brainstem reflexes present
149 Good 70% (58–80) 79% (68–87) 75% (64–84) 74% (62–84)
Baseline AND EEG
reactivity present
149 Good 89% (79–95) 66% (54–76) 87% (75–94) 70% (59–79)
Specificity, sensitivity, PPV, and NPV data are given as percentage (95% CI). For EEG, pattern classification, see Table 1.
cat. = category; CI = confidence interval; EEG = electroencephalographic; NPV = negative predictive value; PPV = positive predictive value;
SSEP = somatosensory evoked potential.
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does EEG-R provide additional information. EEG-R seems
not to be of additional value for prediction of poor outcome;
it might be of additional value for prediction of good out-
come. We found moderate test–retest reliability and poor
agreement between majority vote and consensus meeting
results.
This is the first study to assess the prognostic value
of standardized assessment of EEG-R in a prospective
study, specifically designed for this purpose. The prognos-
tic value of EEG-R has been described before, but mainly
in studies with small sample sizes and with conflicting
results.7,11,18,22–28 Two studies are available that describe
large cohorts, 357 and 373 patients, with reported speci-
ficities for poor outcome of 77% (95% CI = 60–88) and
99% (95% CI = 97–100), respectively.8,10 We obtained a
specificity of 82%. However, these studies were retrospec-
tive, protocols were less extensive and structured, and
other stimuli were used. In contrast to our study, one
study included bilateral nipple pinching.8 This stimulus
was described, albeit in a very small study, as the stimulus
most often evoking EEG-R.29 We deliberately did not
include this stimulus, as it is under ethical debate.29,30
Furthermore, one study described bedside, and therefore
unblinded, scoring of EEG-R, which is the opposite of
our fully blinded analysis.8 Finally, we used best CPC
within 6 months compared to 3 months or at hospital dis-
charge. Early determination of outcome could lead to an
overly pessimistic estimation of outcome, as survivors
recover.
Stimulation protocols between studies vary widely, and
guidelines do not state which stimuli to use.6,15,31 In this study,
stimulations were always executed in the same order, with
increasing intensity of stimulation, and the full stimulus proto-
col was always executed. Only clinical arousal was a reason to
discontinue the protocol. The raters only scored whether they
considered a complete stimulation protocol reactive, regardless
of the exact stimulus type. In futures studies, best practice for
performing stimulations should be investigated.
TABLE 4. Contingency Table of EEG Reactivity and
Outcome
Poor Outcome,
CPC 3–5
Good Outcome,
CPC = 1–2
A
Unreactive
EEG
51 14
Reactive
EEG
19 65
B
Unreactive
EEG
44 14
Reactive
EEG
13 65
C
Unreactive
EEG
48 9
Reactive
EEG
22 70
Outcome was determined by the CPC scale (CPC) and dichotomized
as good (CPC = 1–2) and poor (CPC = 3–5) outcome. EEG reactiv-
ity was based on majority vote (A), based on majority vote with
patients dying of a non-neurological cause excluded (B), and based
on consensus meeting results (C).
CPC = Cerebral Performance Category; EEG = electroencephalographic.
TABLE 5. Predictive Value of Absence of EEG-R for Prediction of Poor Outcome at Different Time Points after
Cardiac Arrest
TP FN FP TN Total Specificity Sensitivity PPV NPV
Unreactive, <12 h 20 2 12 16 50 57% (37–76) 91% (71–99) 63% (52–72) 89% (67–97)
Unreactive, 12–24 h 39 8 16 45 108 74% (61–84) 83% (69–92) 71% (61–79) 85% (75–92)
Unreactive, 24–48 h 33 12 15 25 85 63% (46–77) 73% (58–85) 69% (59–77) 68% (55–78)
Unreactive, >48 h 12 5 1 5 23 83% (36–100) 71% (44–90) 92% (66–99) 50% (31–69)
Unreactive, all time
points
51 19 14 65 149 82% (72–90) 73% (61–83) 79% (67–88) 77% (67–86)
EEG-R and outcome are binary; therefore, values for prediction of good outcome are the exact opposite. Sensitivity and specificity are given as percent-
age (95% confidence interval).
EEG-R = electroencephalographic reactivity; FN = false negative; FP = false positive; NPV = negative predictive value; PPV = positive predictive value;
TN = true negative; TP = true positive.
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Ideally, the specificity of a prognostic test, when
used by itself, should be 100%. We decided to aim for at
least 95% before denominating it reliable. Although
WLST decisions will never be made based on a single pre-
dictor, knowing the prognostic value of each predictor in
the multimodal prognostication process is valuable. EEG-
R was not able to reach our reliability limit, and we there-
fore do not find it sufficiently reliable to be used by itself.
For good outcome prediction, we set a slightly wider limit
(at least 80% specificity), because implications are less
drastic, but even this limit could not be reached. The sen-
sitivity of EEG-R, on the other hand, is much higher than
other clinical tests for prediction of outcome.6 However,
especially for poor outcome, specificity is the main deter-
minant of a reliable marker. EEG-R by itself should there-
fore be used with great caution.
Although only one clinical assessment (EEG-R) is
performed, we report prognostic values of both poor and
good. In our opinion, knowing the predictive value of a
test for both poor and good outcome facilitates a balanced
decision in clinical practice.
Because prognostication after CA is often executed
multimodally, we also assessed the prognostic value of EEG-
R in addition to clinical examination, assessment of SSEPs,
and EEG background patterns. Including EEG-R did not
result in a clinically relevant increase of the specificity for
prediction of outcome. Therefore, we cannot conclude that
EEG-R is of additional value. For prediction of good out-
come, however, specificity increased substantially, and there-
fore EEG-R might be of added value. The increase in
specificity was at the cost of a decrease in sensitivity.
In our cohort, several patients died in the ICU from a
non-neurological cause. This could have decreased our sensi-
tivity for prediction of poor outcome, as EEG-R is primarily
used for prediction of poor neurological outcome. When
these patients were analyzed as having a good outcome,
sensitivity and specificity did not change, and therefore this
had no major influence on our results. The reliability of the
visual assessment of EEG-R was previously described as
questionable.32,33 We thoroughly assessed the reliability and
investigated inter-rater agreement, but also test–retest reli-
ability and comparison between majority vote and consensus
meeting results. The moderate test–retest reliability and poor
agreement between majority vote and consensus meeting are
not in favor of using EEG-R in prognostication after
CA. Part of the problem might be the poorly described defi-
nition of EEG-R. The ACNS defined EEG-R as “Change
in cerebral activity to stimulation.”31 This can be any
change in amplitude and/or frequency, including attenua-
tion of activity. The ACNS definition is open to multiple
interpretations, and there are no cutoffs in terms of fre-
quency or amplitude change for reactivity. Also, these guide-
lines do not state the time window in which a change in the
EEG should be seen to qualify as reactive. In our study, we
assumed a reactive EEG to show changes within several sec-
onds after stimulation. We evaluated EEG-R per stimulus
and did not assess the change in EEG before stimulations
were started compared to after all stimuli were executed.
This approach has been used before, for example, in studies
by the group of Rossetti.8 In line with the ACNS definition,
we excluded muscle artifact from EEG-R. We note that a
reaction to stimulation is potentially not limited to a change
in the EEG or the frequency band we investigated. This
should be evaluated in future studies.
The variability of the human interpretation of EEG-
R could be overcome by quantitative analysis; however,
no algorithm is currently available for clinical applica-
tion.13,25,32,34 A first step toward a clearer definition could
be determining thresholds for changes based on EEG-R
assessments where the decision between reactive and unre-
active was unanimous. For this purpose, assessments
scored as uncertain could be left out.
TABLE 6. Sedation Received by Patients during EEG-R Testing
Reactive, n = 84 Unreactive, n = 65 p
Sedated 61/84 (73%) 34/65 (52%) 0.02
Receiving propofol 57/84 (68%) 31/65 (48%) 0.02
Dose propofol, mg/kg/h 3.33 (2.72–4.00) 3.33 (2.50–3.95) 0.60
Receiving midazolam 8/84 (10%) 8/65 (12%) 0.60
Dose midazolam, mg/kg/h 0.04 (0.02–0.07) 0.1 (0.02–0.12) 0.40
Results are given as n/total (percentage of total) or median (interquartile range). For analysis, 1 EEG-R assessment was selected per patient. This was
the first assessment scored as reactive or, if no reactive assessment was available, the EEG-R assessment where the patient received the lowest dose of
sedation. Four of the reactive patients and 5 of the unreactive patients received both propofol and midazolam.
EEG-R = electroencephalographic reactivity.
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Another feature of the EEG that has been studied in
the context of outcome prediction in comatose patients is
spontaneous EEG variability.35 In comatose patients with
varying etiologies, typically, less spontaneous variability is
associated with worse outcomes.35–37 Possibly, spontane-
ous variability of the EEG, complementary to the
stimulus-induced EEG-R, increases diagnostic accuracy.
Strengths and Limitations
Major strengths of this study are the prospective design,
properly performed a priori power calculation, and
blinding of the EEG readers to outcome, patients’ clinical
status, and other information such as resuscitation details.
Furthermore, our follow-up was long, allowing patients to
recover. Primary outcome was best CPC as opposed to
CPC at a certain time point to prevent an overly pessimis-
tic outcome estimation. We limited the influence of self-
fulfilling prophecy by not notifying the treating physicians
of the results of EEG-R testing. The early EEG back-
ground as measured by the cEEG was not part of our
multimodal decision protocol on prognostication, nor was
EEG-R. WLST was performed in a third of patients with
poor outcome, but the moment of these decisions was not
registered. A bilateral absence of the cortical N20 with the
SSEPs resulted in WLST. If the N20 was not bilaterally
absent, a wait and see policy was used.
Our study has several limitations. Not all 160 patients
deemed necessary could be analyzed, as data from 11 patients
could not be used. Both the expected specificity as used in
our power calculation and the threshold for a reliable predic-
tor could not have been reached if additional patients were
included and 160 analyzable patients were reached.
One center was over-represented in the study. This
could limit generalizability of our results. Another limita-
tion is that video recordings were not included in the
EEG registration. In almost one-quarter of the EEG-R
assessments, raters were uncertain of reactivity for instance
in establishing actual EEG-R or muscle or movement arti-
facts. Possibly, video recordings and/or administration of
muscle relaxants could improve reliable assessment.
According to our protocol for EEG-R testing, stimulations
could be stopped when the patient shows clinical signs of
arousal. This could unblind EEG readers and therefore be
a potential source of bias. In our study, clinical signs of
arousal led to stopping the stimulations in only 1% of the
sample and is therefore unlikely to have imposed a bias on
the results.
Conclusion
Our findings suggest that EEG-R by itself is not a reliable
predictor for either poor or good outcome in comatose
patients after CA. In addition to clinical examination,
SSEPs, and EEG background pattern, we found no addi-
tional value of EEG-R. For prediction of good neurologi-
cal outcome, EEG-R increased specificity substantially.
However, reliable assessment of EEG-R remains an issue.
Although our data do not support the use of EEG-R for
poor outcome prediction in patients after CA, it may have
added value for prediction of good outcome.
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